Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report
Transpl Immunol. 2023 Sep 29;81:101937. doi: 10.1016/j.trim.2023.101937. Online ahead of print.ABSTRACTThe study aimed to determine the influence of induction therapy on the acute cellular rejection (ACR) index in adult heart transplant recipients during the one-year observation. The study population consisted of 256 consecutive adult patients (pts), aged 51.5 (±11.9) years, 199 (77%) men treated with orthotopic heart transplantation (OHT) in the period between 2015 and 2020 in a single high-volume heart transplant center. The endomyocardial biopsies (EMBs) were performed according to the protocol consisting of 7 protocol...
Source: Transplant Immunology - October 1, 2023 Category: Transplant Surgery Authors: Agnieszka Kuczaj Szymon Warwas Micha ł Zakliczyński Szymon Pawlak Piotr Przyby łowski Joanna Śliwka Tomasz Hrapkowicz Source Type: research
Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report
Transpl Immunol. 2023 Sep 29;81:101937. doi: 10.1016/j.trim.2023.101937. Online ahead of print.ABSTRACTThe study aimed to determine the influence of induction therapy on the acute cellular rejection (ACR) index in adult heart transplant recipients during the one-year observation. The study population consisted of 256 consecutive adult patients (pts), aged 51.5 (±11.9) years, 199 (77%) men treated with orthotopic heart transplantation (OHT) in the period between 2015 and 2020 in a single high-volume heart transplant center. The endomyocardial biopsies (EMBs) were performed according to the protocol consisting of 7 protocol...
Source: Transplant Immunology - October 1, 2023 Category: Transplant Surgery Authors: Agnieszka Kuczaj Szymon Warwas Micha ł Zakliczyński Szymon Pawlak Piotr Przyby łowski Joanna Śliwka Tomasz Hrapkowicz Source Type: research
Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report
Transpl Immunol. 2023 Sep 29;81:101937. doi: 10.1016/j.trim.2023.101937. Online ahead of print.ABSTRACTThe study aimed to determine the influence of induction therapy on the acute cellular rejection (ACR) index in adult heart transplant recipients during the one-year observation. The study population consisted of 256 consecutive adult patients (pts), aged 51.5 (±11.9) years, 199 (77%) men treated with orthotopic heart transplantation (OHT) in the period between 2015 and 2020 in a single high-volume heart transplant center. The endomyocardial biopsies (EMBs) were performed according to the protocol consisting of 7 protocol...
Source: Transplant Immunology - October 1, 2023 Category: Transplant Surgery Authors: Agnieszka Kuczaj Szymon Warwas Micha ł Zakliczyński Szymon Pawlak Piotr Przyby łowski Joanna Śliwka Tomasz Hrapkowicz Source Type: research
Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report
Transpl Immunol. 2023 Sep 29:101937. doi: 10.1016/j.trim.2023.101937. Online ahead of print.ABSTRACTThe study aimed to determine the influence of induction therapy on the acute cellular rejection (ACR) index in adult heart transplant recipients during the one-year observation. The study population consisted of 256 consecutive adult patients (pts), aged 51.5 (±11.9) years, 199 (77%) men treated with orthotopic heart transplantation (OHT) in the period between 2015 and 2020 in a single high-volume heart transplant center. The endomyocardial biopsies (EMBs) were performed according to the protocol consisting of 7 protocolary...
Source: Transplant Immunology - October 1, 2023 Category: Transplant Surgery Authors: Agnieszka Kuczaj Szymon Warwas Micha ł Zakliczyński Szymon Pawlak Piotr Przyby łowski Joanna Śliwka Tomasz Hrapkowicz Source Type: research
Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report
Transpl Immunol. 2023 Sep 29:101937. doi: 10.1016/j.trim.2023.101937. Online ahead of print.ABSTRACTThe study aimed to determine the influence of induction therapy on the acute cellular rejection (ACR) index in adult heart transplant recipients during the one-year observation. The study population consisted of 256 consecutive adult patients (pts), aged 51.5 (±11.9) years, 199 (77%) men treated with orthotopic heart transplantation (OHT) in the period between 2015 and 2020 in a single high-volume heart transplant center. The endomyocardial biopsies (EMBs) were performed according to the protocol consisting of 7 protocolary...
Source: Transplant Immunology - October 1, 2023 Category: Transplant Surgery Authors: Agnieszka Kuczaj Szymon Warwas Micha ł Zakliczyński Szymon Pawlak Piotr Przyby łowski Joanna Śliwka Tomasz Hrapkowicz Source Type: research
Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report
Transpl Immunol. 2023 Sep 29:101937. doi: 10.1016/j.trim.2023.101937. Online ahead of print.ABSTRACTThe study aimed to determine the influence of induction therapy on the acute cellular rejection (ACR) index in adult heart transplant recipients during the one-year observation. The study population consisted of 256 consecutive adult patients (pts), aged 51.5 (±11.9) years, 199 (77%) men treated with orthotopic heart transplantation (OHT) in the period between 2015 and 2020 in a single high-volume heart transplant center. The endomyocardial biopsies (EMBs) were performed according to the protocol consisting of 7 protocolary...
Source: Transplant Immunology - October 1, 2023 Category: Transplant Surgery Authors: Agnieszka Kuczaj Szymon Warwas Micha ł Zakliczyński Szymon Pawlak Piotr Przyby łowski Joanna Śliwka Tomasz Hrapkowicz Source Type: research
Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report
Transpl Immunol. 2023 Sep 29:101937. doi: 10.1016/j.trim.2023.101937. Online ahead of print.ABSTRACTThe study aimed to determine the influence of induction therapy on the acute cellular rejection (ACR) index in adult heart transplant recipients during the one-year observation. The study population consisted of 256 consecutive adult patients (pts), aged 51.5 (±11.9) years, 199 (77%) men treated with orthotopic heart transplantation (OHT) in the period between 2015 and 2020 in a single high-volume heart transplant center. The endomyocardial biopsies (EMBs) were performed according to the protocol consisting of 7 protocolary...
Source: Transplant Immunology - October 1, 2023 Category: Transplant Surgery Authors: Agnieszka Kuczaj Szymon Warwas Micha ł Zakliczyński Szymon Pawlak Piotr Przyby łowski Joanna Śliwka Tomasz Hrapkowicz Source Type: research
Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report
Transpl Immunol. 2023 Sep 29:101937. doi: 10.1016/j.trim.2023.101937. Online ahead of print.ABSTRACTThe study aimed to determine the influence of induction therapy on the acute cellular rejection (ACR) index in adult heart transplant recipients during the one-year observation. The study population consisted of 256 consecutive adult patients (pts), aged 51.5 (±11.9) years, 199 (77%) men treated with orthotopic heart transplantation (OHT) in the period between 2015 and 2020 in a single high-volume heart transplant center. The endomyocardial biopsies (EMBs) were performed according to the protocol consisting of 7 protocolary...
Source: Transplant Immunology - October 1, 2023 Category: Transplant Surgery Authors: Agnieszka Kuczaj Szymon Warwas Micha ł Zakliczyński Szymon Pawlak Piotr Przyby łowski Joanna Śliwka Tomasz Hrapkowicz Source Type: research
Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report
Transpl Immunol. 2023 Sep 29:101937. doi: 10.1016/j.trim.2023.101937. Online ahead of print.ABSTRACTThe study aimed to determine the influence of induction therapy on the acute cellular rejection (ACR) index in adult heart transplant recipients during the one-year observation. The study population consisted of 256 consecutive adult patients (pts), aged 51.5 (±11.9) years, 199 (77%) men treated with orthotopic heart transplantation (OHT) in the period between 2015 and 2020 in a single high-volume heart transplant center. The endomyocardial biopsies (EMBs) were performed according to the protocol consisting of 7 protocolary...
Source: Transplant Immunology - October 1, 2023 Category: Transplant Surgery Authors: Agnieszka Kuczaj Szymon Warwas Micha ł Zakliczyński Szymon Pawlak Piotr Przyby łowski Joanna Śliwka Tomasz Hrapkowicz Source Type: research
Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report
Transpl Immunol. 2023 Sep 29:101937. doi: 10.1016/j.trim.2023.101937. Online ahead of print.ABSTRACTThe study aimed to determine the influence of induction therapy on the acute cellular rejection (ACR) index in adult heart transplant recipients during the one-year observation. The study population consisted of 256 consecutive adult patients (pts), aged 51.5 (±11.9) years, 199 (77%) men treated with orthotopic heart transplantation (OHT) in the period between 2015 and 2020 in a single high-volume heart transplant center. The endomyocardial biopsies (EMBs) were performed according to the protocol consisting of 7 protocolary...
Source: Transplant Immunology - October 1, 2023 Category: Transplant Surgery Authors: Agnieszka Kuczaj Szymon Warwas Micha ł Zakliczyński Szymon Pawlak Piotr Przyby łowski Joanna Śliwka Tomasz Hrapkowicz Source Type: research
Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report
Transpl Immunol. 2023 Sep 29:101937. doi: 10.1016/j.trim.2023.101937. Online ahead of print.ABSTRACTThe study aimed to determine the influence of induction therapy on the acute cellular rejection (ACR) index in adult heart transplant recipients during the one-year observation. The study population consisted of 256 consecutive adult patients (pts), aged 51.5 (±11.9) years, 199 (77%) men treated with orthotopic heart transplantation (OHT) in the period between 2015 and 2020 in a single high-volume heart transplant center. The endomyocardial biopsies (EMBs) were performed according to the protocol consisting of 7 protocolary...
Source: Transplant Immunology - October 1, 2023 Category: Transplant Surgery Authors: Agnieszka Kuczaj Szymon Warwas Micha ł Zakliczyński Szymon Pawlak Piotr Przyby łowski Joanna Śliwka Tomasz Hrapkowicz Source Type: research
Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report
Transpl Immunol. 2023 Sep 29:101937. doi: 10.1016/j.trim.2023.101937. Online ahead of print.ABSTRACTThe study aimed to determine the influence of induction therapy on the acute cellular rejection (ACR) index in adult heart transplant recipients during the one-year observation. The study population consisted of 256 consecutive adult patients (pts), aged 51.5 (±11.9) years, 199 (77%) men treated with orthotopic heart transplantation (OHT) in the period between 2015 and 2020 in a single high-volume heart transplant center. The endomyocardial biopsies (EMBs) were performed according to the protocol consisting of 7 protocolary...
Source: Transplant Immunology - October 1, 2023 Category: Transplant Surgery Authors: Agnieszka Kuczaj Szymon Warwas Micha ł Zakliczyński Szymon Pawlak Piotr Przyby łowski Joanna Śliwka Tomasz Hrapkowicz Source Type: research
Extended duration letermovir in allogeneic hematopoietic stem cell transplant
CONCLUSION: The results of this study suggest that extended duration letermovir prophylaxis may be associated with less CMV reactivation compared to the standard duration of prophylaxis.PMID:37770000 | DOI:10.1016/j.trim.2023.101936 (Source: Transplant Immunology)
Source: Transplant Immunology - September 28, 2023 Category: Transplant Surgery Authors: Breanna Hinman James Cox Godsfavour Umoru Rammurti Kamble Will Musick Source Type: research
Extended duration letermovir in allogeneic hematopoietic stem cell transplant
CONCLUSION: The results of this study suggest that extended duration letermovir prophylaxis may be associated with less CMV reactivation compared to the standard duration of prophylaxis.PMID:37770000 | DOI:10.1016/j.trim.2023.101936 (Source: Transplant Immunology)
Source: Transplant Immunology - September 28, 2023 Category: Transplant Surgery Authors: Breanna Hinman James Cox Godsfavour Umoru Rammurti Kamble Will Musick Source Type: research
Extended duration letermovir in allogeneic hematopoietic stem cell transplant
CONCLUSION: The results of this study suggest that extended duration letermovir prophylaxis may be associated with less CMV reactivation compared to the standard duration of prophylaxis.PMID:37770000 | DOI:10.1016/j.trim.2023.101936 (Source: Transplant Immunology)
Source: Transplant Immunology - September 28, 2023 Category: Transplant Surgery Authors: Breanna Hinman James Cox Godsfavour Umoru Rammurti Kamble Will Musick Source Type: research
